Faculty

Jared Baeten

Professor, Epidemiology
Professor, Global Health
Professor, Medicine - Allergy and Infectious Dis.

206-520-3808
jbaeten@uw.edu

Education

MD Medicine, University of Washington, 2003
PhD Epidemiology, University of Washington, 2001
BA Chemistry, Religious Studies, Washington University, 1995

Contact

206-520-3808
jbaeten@uw.edu

Office Box 359927
Ninth and Jefferson Building 12th Floor
908 Jefferson Street
Box 359927
Seattle, WA 98104

Bio

Dr. Baeten is Professor of Global Health, Medicine, and Epidemiology at the University of Washington. His research focuses on the prevention of HIV and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV transmission, work at the interface of HIV prevention and reproductive health, and behavioral, translational, and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials that demonstrated the efficacy of oral tenofovir-based pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring for protection against HIV acquisition; he also was part of the leadership of the ECHO Study, which examined HIV risk related to hormonal contraceptive use in a randomized trial. He is Co-Principal Investigator of the NIH-funded Microbicides Trials Network.

Research Interests

  • HIV/AIDS and other STDs
  • Women
  • Africa

Recent Publications (PubMed)

Implementation of a fully remote randomized clinical trial with cardiac monitoring.
(2021)
Commun Med (Lond) 1(): 62
Mayfield JJ, Chatterjee NA, Noseworthy PA, Poole JE, Ackerman MJ, Stewart J, Kissinger PJ, Dwyer J, Hosek S, Oyedele T, Paasche-Orlow MK, Paolino K, Friedman PA, Waters C, Moreno J, Leingang H, Heller KB, Morrison SA, Krows ML, Barnabas RV, Baeten J, Johnston C, COVID-19 Early Treatment Team., Sridhar AR

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
(2022 May 12)
N Engl J Med 386(19): 1793-1803
Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, Baeten JM, Molina JM, CAPELLA Study Investigators.

Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring.
(2022 May 10)
AIDS Behav
Katz AWK, Balán IC, Reddy K, Etima J, Weber K, Tauya T, Atujuna M, Scheckter R, Ngure K, Soto-Torres L, Mgodi N, Palanee-Phillips T, Baeten JM, van der Straten A

Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya.
(2022 Apr 27)
J Acquir Immune Defic Syndr
Zewdie K, Kiptinness C, Ngure K, Kipkurui N, Wairimu N, Ambiyo F, Mugo NR, Baeten JM, Mugwanya KK

Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials.
(2022 Apr 26)
Clin Infect Dis
Garcia-Cremades M, Vučićević K, Hendrix CW, Jayachandran P, Jarlsberg L, Grant R, Celum CL, Martin M, Baeten JM, Marrazzo J, Anderson P, Choopanya K, Vanichseni S, Glidden DV, Savic RM

Show complete publication list